The billionaire tech mogul's testimony was part of a landmark social media addiction trial in Los Angeles. The jury's verdict in the case could shape how some 1,600 other pending cases from families and school districts are resolved.

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.

Aside from inflation, where you live could have a big impact on what’s driving your higher electric bill.

Anthropic is one of the world's most powerful AI firms. New Yorker writer Gideon Lewis-Kraus explains how they're trying to make chatbot Claude more ethical, and the implications of AI's widening use.

The case is seen as a test of social media's legal responsibility for platform design features that plaintiffs' lawyers say exacerbated mental health issues in young people.

As CBS's parent company makes a final play for Warner Bros. Discovery, CBS faces scrutiny over claims it blocked a Stephen Colbert interview while Anderson Cooper stepped down from 60 Minutes.

While the unemployment rate seems stable, the number of people who've been out of work for six months or more has been ticking up.

Cocaine has made a roaring comeback, and it's having some big negative effects in the U.S. and around the world.

As prediction markets boom, competition is heating up. So traders go the extra mile for a fraction-of-a-second advantage or to sleuth out information nobody else has. It can lead to a huge payday.

The Chinese AI company DeepSeek shocked markets last year with a high-quality, low-cost model. It's now become clearer that China and the U.S. are running two different AI races.